Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats - Wikidata - wikimedia - TriplyDB

Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats

Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats

http://www.wikidata.org/entity/Q35760670

about

Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step Extracellular matrix and liver disease Efficacies of rosiglitazone and retinoin on bleomycin-induced pulmonary fibrosis in rats.Pioglitazone Attenuates Cystic Burden in the PCK Rodent Model of Polycystic Kidney Disease.Thiazolidinediones and hepatic fibrosis: don't wait too long.The Role of PPARs in Lung Fibrosis.The crucial role of cholangiocytes in cholangiopathies PPAR and liver injury in HIV-infected patients.Pathophysiology of NASH: perspectives for a targeted treatment.Therapeutic targets in liver fibrosis.Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside.Pharmacological agents for NASH.The Role of PPARgamma in Hepatocellular Carcinoma.The stellate cell system (vitamin A-storing cell system).PPARs and nonalcoholic fatty liver disease.Novel Anti-fibrotic Therapies.Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis.

P2860

Q26771518-73A3BE5E-014D-4461-9694-23C91272EA24 Q26823060-0B270D9B-AD23-4EAD-80C9-88C37CFBC1BD Q33847144-4D37C089-8A38-40E9-95DD-5CB9A82DC30F Q34260759-7104DB8B-E8EA-4EB1-91D1-24B297CAD459 Q35760700-605ED788-7DDC-4D89-87C4-01722116985C Q35925362-80DB77D8-B9DE-4FD6-8258-DFB5BA4FD633 Q36113261-DE481171-6BD6-4A6A-971D-72F5D4F5FE95 Q37458203-DC796B9A-0D1F-48D8-BBD9-8780ABD9D5BE Q37699476-86426AB6-0F07-4E80-B30E-D6441E787245 Q37828321-2221E801-AFDE-46EE-AE9A-2E2C29664314 Q38018841-F54C0F6C-D434-4354-A34D-2209286DA6AB Q38152646-96C4355E-DF45-4EDA-B833-15DCCADF24CE Q38621590-1914BED6-3655-4992-9CD0-789C66A63FFD Q38744473-FF9DBD5B-076D-4338-931F-C9DDE907B683 Q39029023-DEECA648-1E92-46B2-ACDA-D58587C9E570 Q39377055-6EC76211-C66D-452D-BEC8-A172B3027141 Q41926996-5BFA0120-90F6-41EA-8AFE-21381FFD7766 Q54595302-1DC46C72-ABBD-4A24-8C1A-53AC6597A37A

P2860

Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats

http://www.wikidata.org/entity/Q35760670

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats

@ast

Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats

@en

type

label

Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats

@ast

Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats

@en

prefLabel

Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats

@ast

Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats

@en

P1433

Q35760670-CBA4BB24-34D6-42CC-AF1D-F31B8C746AB3

P1476

Q35760670-AADD0559-E921-4F54-832A-6A5401FF8968

P2093

Q35760670-07115843-19BA-43D7-ADA6-57DA1210748D

Q35760670-4C0D06D6-BFFA-43B7-80FC-6B9F020A4A72

Q35760670-9E4F2B55-CC7A-4345-9D51-E62C4112B955

Q35760670-A2F61F0A-925B-4F55-A4BF-AFD79C42EF40

P2860

Q35760670-05F7E18E-4F5F-45F3-927C-F1B5D1189436

Q35760670-07CD215E-A68C-4B15-B03A-E6BA1A0C17A8

Q35760670-1394910C-9701-43F4-9AA8-EC578DE29B66

Q35760670-13C01B9F-1CB6-4826-9653-C634C855DC53

Q35760670-14520611-F701-4EBB-B6CF-3D9DDF086B6F

Q35760670-1D0649F4-EEC0-4B62-9A60-FCAA940B22EF

Q35760670-1F43E0F2-2FA8-4755-A852-B0F065347C22

Q35760670-25135267-2E9C-4B0F-BCBF-D7D4FE81AF83

Q35760670-2E79CD56-B8FC-43E3-A0F9-8A89824B0F7D

Q35760670-31A92B1F-3FD1-43E5-8638-8DD99B379072

P304

Q35760670-71F0B3AD-2A7D-4368-AE4E-B1AC37CF37BD

P31

Q35760670-5FA625C8-C2A3-4B28-92D3-895B10877ED0

P356

Q35760670-038656C6-096C-4958-A698-DFA8F41360A1

P407

Q35760670-340C247D-313D-4ED2-907F-AC71F81473C0

P433

Q35760670-B464ECA2-1678-47A2-ABCF-1C1D864346FF

P478

Q35760670-E6410625-4E7A-4148-B5C8-5CC04A270212

P577

Q35760670-7C0314D2-5FE8-4DEA-BDDA-B8BA40DC4DDF

P5875

Q35760670-16F4AE81-95CF-4A1D-8CAA-A000AA5591B5

P698

Q35760670-BDD717A3-E1EF-43DE-9B03-2492C44CDD60

P932

Q35760670-3C560F5A-4C4D-41AA-9B61-04D8E550392E

P356

GUT.2005.079194

P1433

P1476

Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats

@en

P2093

C Sempoux

http://www.w3.org/2001/XMLSchema#string

I A Leclercq

http://www.w3.org/2001/XMLSchema#string

P Stärkel

http://www.w3.org/2001/XMLSchema#string

Y Horsmans

http://www.w3.org/2001/XMLSchema#string

P2860

PPARbeta regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation

Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors

The Biology of Peroxisome Proliferator-Activated Receptors: Relationship With Lipid Metabolism and Insulin Sensitivity

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

PPARs and the complex journey to obesity

Histological grading and staging of chronic hepatitis

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury.

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

P304

1020-1029

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.2005.079194

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2006-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7291652

http://www.w3.org/2001/XMLSchema#string

P698

16484506

http://www.w3.org/2001/XMLSchema#string

P932

1856308

http://www.w3.org/2001/XMLSchema#string